Intensive Review of Nephrology

Continuing Education

Half a blue transparent torso with bright orange kidney and text "The Comprehensive Clinical Update and Board Review"

August 10 - 14, 2026

Course schedule

This live online CME program provides a comprehensive review of the state of the art in Nephrology. Leading clinical faculty of Harvard Medical School offer accelerated learning for clinicians to ensure they are up to date across all major areas of Nephrology. They also provide intensive preparation for physicians preparing to certify or recertify by taking the Nephrology ABIM board examination.

Live Online

This program uses state-of-the-art streaming technology to present sessions online in real time. Participants can attend from any location, and can interact with faculty via live chat.

Additionally, all sessions will be recorded and made available to participants for online viewing for 60 days after the end of the course.

All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 30 days in order to receive CME credit.)

$1,195 Save with early registration

Save $100. The tuition listed above is for physicians; see the course fee table for pricing for other health professionals. To ensure your participation at the lowest possible cost, early registration is strongly recommended.

Fee increases to $1,295 after June 30, 2026

Continuing Education

Earn up to:

» 51.25 AMA PRA Category 1 Credits™

» 51.25 ABIM MOC points

» 51.25 ECME Credits^®

» Commensurate credits through the Royal College of Physicians and Surgeons of Canada

View all

5 Days

This intensive program, which is among the highest-rated Harvard Medical School CME courses, updates busy clinicians on current best practices in the evaluation, diagnosis, and management of renal conditions.

Overview

The Comprehensive Clinical Update and Board Review

Intensive Review of Nephrology is an online course, using live streaming, electronic Q&A, and other remote learning technologies.

With over 70 interactive lectures, case discussions, board preparation sessions, and supplementary lectures, this CME program provides a comprehensive review of state-of-the-art nephrology practices. It offers accelerated learning for:

► Clinicians seeking a practical and comprehensive review that ensures they are up to date across all major areas of nephrology:

The latest options for diagnosis: what to choose, when, and why
Current evidence-based treatment and care management strategies to optimize patient outcomes
Improved approaches to common and complex clinical challenges
Navigating clinical controversies
How to avoid medical mistakes
Additional details

► Physicians preparing to certify or recertify who seek a thorough, proven preparatory course in advance of their taking the Nephrology ABIM board examination:

Daily board review questions and sessions
Sessions to guide efficient preparation and study
Comprehensive syllabus and home study guide
Additional details

Comprehensive Education
This course spans all areas of nephrology. Sessions are led by experts in their respective fields. Coverage includes:

Electrolytes and Acid-Base
Glomerulonephritis
Acute Kidney Injury
Chronic Kidney Disease
Genetic Kidney Disease
Vascular Disease
Hypertension
End-Stage Renal Disease
Transplantation
Onconephrology: Cancer and the Kidney
Pregnancy and Renal Disease
Point-of-Care Renal Ultrasound
AI in Nephrology

2026 Program Highlights

Genetic testing for improved diagnosis, prognosis, and selection of therapy
Introduction to point-of-care ultrasound: fundamentals for optimal image acquisition and accurate interpretation
Physical exam of the dialysis access
High-dose hemodiafiltration versus high-flux hemodialysis in the management of ESKD
Further expansion of the roles of SGLT2 inhibitors, GLP-1 agonists, and finerenone in diabetic and non-diabetic kidney disease
Novel immunosuppressive agents for glomerulonephritis, including the evolving role of Chimeric Antigen Receptor T-cell therapy (CAR-T)
An introduction to xenotransplantation
The role of renal-dedicated palliative care (“KidneyPal”) in Nephrology and the principles of conservative kidney management

In addition to being live streamed, all sessions will be recorded and placed in the online course library, enabling registrants to view them at their convenience. Recordings will be available for viewing for 60 days after the conclusion of the course. All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 30 days in order to receive CME credit.)

Developed and Offered By:

Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Mass General Brigham.

Schedule

This program is among the highest-rated Harvard Medical School CME courses.

All agenda sessions are in Eastern Time.

Please note that program changes/substitutions may be made without notice.

View and Print Full Schedule

Monday, August 10, 2026

Day 1

Monday, August 10, 2026

Tuesday, August 11, 2026

Day 2

Tuesday, August 11, 2026

Wednesday, August 12, 2026

Day 3

Wednesday, August 12, 2026

Thursday, August 13, 2026

Day 4

Thursday, August 13, 2026

Friday, August 14, 2026

Day 5

Friday, August 14, 2026

Optimized for Distance Learning

The 2026 program has been optimized for distance learning.

In addition to being live streamed, all sessions and Q & A discussions will be recorded and made available to participants for online viewing for 60 days after the end of the course. This on-demand archive will permit those in different time zones or who have scheduling conflicts to avoid missing out on any sessions that are important to them. In addition, participants can review sessions to reinforce key learning points.

Learning Objectives

Upon completion of this course, participants will be able to:

Summarize current/recommended nephrology guidelines in clinical practice
Explain the differential diagnosis of complex clinical presentations of patients with renal disorders
Identify/integrate current therapeutic options for specific renal disorders
Review and interpret up-to-date literature relevant to clinical practice
Describe pathophysiological mechanisms as they apply to management of renal disease
Synthesize teachings to better performance on the ABIM Nephrology certification/recertification examinations

Faculty

Course Directors

David B. Mount

MD, FRCP(C)

Assistant Professor of Medicine, Harvard Medical School
Associate Chief and Clinical Chief, Renal Division
Co-Director, Glomerular Diseases Clinic
Director, Dialysis Services, Department of Medicine, Brigham and Women's Hospital
Physician, VA Boston Healthcare System

Jamil R. Azzi

MD, PhD

Associate Professor of Medicine, Harvard Medical School
Medical Director, Vascularized Composite Allotransplantation
Interim Director, Kidney and Pancreas Transplantation
Director, Kidney Transplant Fellowship
Engineering in Medicine, Brigham and Women’s Hospital
Associate Physician, Renal Division, Department of Medicine, Brigham and Women's Hospital

Gearoid McMahon

MB, BCH, FASN

Assistant Professor of Medicine, Harvard Medical School
Director, ICU Nephrology
Assistant Clinical Director
Associate Physician, Renal Division, Brigham and Women's Hospital

Alice M. Sheridan

Assistant Professor of Medicine, Harvard Medical School
Program Director, Combined Brigham and Women's Hospital/Massachusetts General Hospital Renal Fellowship Program
Associate Physician, Renal Division, Department of Medicine, Brigham and Women's Hospital

Adina S. Voiculescu

Assistant Professor of Medicine, Harvard Medical School
Associate Physician, Director of Ultrasound in Nephrology
Renal Division, Department of Medicine, Brigham and Women's Hospital
Chief of Nephrology, Brigham and Women’s Faulkner Hospital

Harvard Medical School Faculty

Gerald B. Appel, MD, Professor of Clinical Medicine, Columbia University College of Physicians & Surgeons; Director of Clinical Nephrology, Columbia University Medical Center, New York, NY

Joanne M. Bargman, MD, FRCPC, Professor of Medicine, University of Toronto; Director, Peritoneal Dialysis Program, University Health Network, Toronto, Ontario, Canada

Laurence H. Beck, Jr., MD, PhD, Associate Professor, Boston University Chobanian & Avedisian School of Medicine; Renal Section, Department of Medicine, Boston Medical Center, Boston, MA

Ramon G. Bonegio, MD, Clinical Associate Professor, Boston University Chobanian & Avedisian School of Medicine; Renal Section, Boston Medical Center, Boston, MA

David Bushinsky, MD, Professor of Medicine and Pharmacology and Physiology, University of Rochester School of Medicine; Nephrology Division, University of Rochester Medical Center, Rochester, NY

Fouad T. Chebib, MD, FASN, Associate Professor of Medicine, Mayo Clinic College of Medicine; Consultant, Division of Nephrology and Hypertension; Director, Mayo Clinic Florida PKD Center of Excellence; Director, Discovery and Translational PKD Research Lab; Research Chair, Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, FL

Jean M. Francis, MD, Associate Professor, Boston University Chobanian & Avedisian School of Medicine; Medical Director, Kidney Transplant Program, Renal Section, Boston Medical Center; Medical Director, Pancreas Transplant Program, Renal Division, Department of Medicine, Brigham and Women’s Hospital

Richard J. Glassock, MD, Professor Emeritus, Department of Medicine, Geffen School of Medicine, University of California, Los Angeles, CA

Charlotte E. Goldfine, MD, Yale School of Medicine, Department of Emergency Medicine, Yale New Haven Hospital, New Haven, CT

Katelyn Lei, PharmD, BCTXP, Clinical Pharmacist, Abdominal Organ Transplant, Brigham and Women’s Hospital

Jayme E. Locke, MD, MPH, FACS, FAST, Professor of Surgery; Chief, Division of Transplantation; Arnold G. Diethelm Endowed Chair in Transplantation Surgery, Division of Transplantation, Department of Surgery, University of Alabama at Birmingham (UAB) Heersink School of Medicine; Director, UAB Comprehensive Transplant Institute, UAB Medicine, UAB Hospital

Sayeed Malek, MD, FACS, Clinical Associate Professor of Surgery, Boston University Chobanian & Avedisian School of Medicine; Chief of Transplant Surgery, Department of Kidney Transplant Surgery, Boston Medical Center, Boston, MA

Naoka Murakami, MD, PhD, Assistant Professor of Medicine, WashU Medicine; Division of Nephrology John T. Milliken Department of Medicine, WashU Medicine, St. Louis, MO

Opeyemi A. Olabisi, MD, PhD, Associate Professor of Medicine; Chief, Division of Nephrology, Department of Medicine; Member of Duke Molecular Physiology Institute, Duke University Medical Center, Duke University School of Medicine, Durham, NC

Karandeep Singh, MD, MMSc, Associate Professor of Medicine, UC San Diego; Joan and Irwin Jacobs Chancellor’s Endowed Chair in Digital Health Innovation in Biomedical Informatics; Chief Health AI Officer at UC San Diego Health

Alan S.L. Yu, MB BChir, Harry Statland and Solon Summerfield Professor of Medicine; Director, Division of Nephrology and Hypertension and The Kidney Institute, University of Kansas Medical Center, Kansas City, KS

Guest Faculty

Gerald B. Appel, MD, Professor of Clinical Medicine, Columbia University College of Physicians & Surgeons; Director of Clinical Nephrology, Columbia University Medical Center, New York, NY

Joanne M. Bargman, MD, FRCPC, Professor of Medicine, University of Toronto; Director, Peritoneal Dialysis Program, University Health Network, Toronto, Ontario, Canada

Laurence H. Beck, Jr., MD, PhD, Associate Professor, Boston University Chobanian & Avedisian School of Medicine: Renal Section, Department of Medicine, Boston Medical Center, Boston, MA

Ramon G. Bonegio, MD, Clinical Associate Professor, Boston University Chobanian & Avedisian School of Medicine; Renal Section, Boston Medical Center, Boston, MA

David Bushinsky, MD, Professor of Medicine and Pharmacology and Physiology, University of Rochester School of Medicine; Nephrology Division, University of Rochester Medical Center, Rochester, NY

Richard J. Glassock, MD, Professor Emeritus, Department of Medicine, Geffen School of Medicine, University of California, Los Angeles, CA

Charlotte E. Goldfine, MD, Yale School of Medicine, Department of Emergency Medicine, Yale New Haven Hospital, New Haven, CT

Katelyn Lei, PharmD, BCTXP, Clinical Pharmacist, Abdominal Organ Transplant, Brigham and Women’s Hospital

Naoka Murakami, MD, PhD, Assistant Professor of Medicine, WashU Medicine; Division of Nephrology John T. Milliken Department of Medicine, WashU Medicine, St. Louis, MO

Opeyemi A. Olabisi MD, PhD, Associate Professor of Medicine; Chief, Division of Nephrology, Department of Medicine; Member of Duke Molecular Physiology Institute, Duke University Medical Center, Duke University School of Medicine, Durham, NC

Course Fees

Registration Details

Registrations for Harvard Medical School CME programs are made via our secure online registration system. At the end of the registration process, a $10 non-refundable processing fee will be added to your registration.

Upon receipt of your paid registration, an email confirmation will be sent to you. Be sure to include an email address that you check frequently. Your email address is used for critical information, including registration confirmation, evaluation, and certificate.

Please review the cancellation policy.

Early Registration Deadline: June 30, 2026

Role	Course Fee	Early Registration Course Fee
Physician (MD/DO)	$1,295	$1,195
Nurse (RN/APRN)	$995	$895
PA	$995	$895
Resident/Fellow	$895	$795
Allied Health Professional / Other	$995	$895

Your tuition includes all course materials via download.

All sessions will be recorded as they are live streamed and added to the online course video library, so that registrants can review them at their convenience. The entire video library will be available for 60 days after the conclusion of the course.

Click Here to Register

Accreditation

In support of improving patient care, Harvard Medical School is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

Badge for Jointly Accredited Provider with Commendation Interprofessional Continuing Education

The Harvard Medical School designates this live activity for a maximum of 51.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 51.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

Nurse Practitioners and Registered Nurses

For the purpose of recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center accept AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education). We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

Physician Assistants

The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

European Accreditation

The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found on the European Union of Medical Specialties website.

Canadian Accreditation

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

Competencies

ABMS/ACGME Competencies

This course is designed to meet the following American Board of Medical Specialties (ABMS) / Accreditation Council for Graduate Medical Educational (ACGME) competencies:

Patient Care and Procedural Skills
Medical Knowledge
Practice-Based Learning and Improvement

Disclaimer & Disclosure

Disclaimer Policy

CME activities accredited by Harvard Medical School are offered solely for educational purposes and do not constitute any form of certification of competency. Practitioners should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind.

Note: AMA PRA Category 1 Credit™ is calculated based on submission of a preliminary agenda and may be subject to change.

Disclosure

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education (ACCME), course planners, speakers, and content reviewers have been asked to disclose any relationships they have to companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Registration for courses managed by Harvard Medical School can only be completed through Harvard Medical School’s official registration portal: cmeregistration.hms.harvard.edu. Attendee registrations made through any other sites cannot be honored and will not be refunded. Please report any unauthorized websites or solicitations for registrations.

In order to comply with applicable U.S. export control and sanctions regulations, Harvard Medical School prohibits access to and use of Harvard Medical School educational offerings, programs and resources to individuals from certain sanctioned regions or who are otherwise subject to U.S. government sanctions, unless appropriate authorization is in place.

Program Topics

Clinical Practice

Intensive Review of Nephrology

On This Page

Overview

The Comprehensive Clinical Update and Board Review

Developed and Offered By:

Who Should Participate

Schedule

Monday, August 10, 2026

Welcome Remarks/Announcements

Renal Physiology for the Boards

Basic Concepts of Immunology in Autoimmune Kidney Disease

Faculty Q&A

Renal Pathology in 2026: Part 1

Renal Pathology in 2026: Part 2

Current Approaches to Urine Sediment Analysis

Faculty Q&A

IgA Nephropathy

Metabolic Management of Kidney Stones

AI in Nephrology: Clinical Applications

Faculty Q&A

Update on Lupus Nephritis

Membranous Nephropathy

Anemia Management: Update and Best Practices

Faculty Q&A

Adjourn Live Program

Self-Paced Study

Glomerulonephritis: Questions & Answers Session

Must-Know Clinical Images in Nephrology

Must-Know Board Zebras

Nephrology Board Review Practice 1

Nephrology Board Review Practice 2

Tuesday, August 11, 2026

Morning Announcements

Acid-Base Disorders I: Anion Gap Metabolic Acidosis

Acid-Base Disorders II: Non-Gap Acidosis and Metabolic Alkalosis

Hyponatremia and Hypernatremia

Hypokalemia and Hyperkalemia

Important New Trials in GN

Genetics and Kidney Disease

Update on Polycystic Kidney Disease

Faculty Q&A

Pediatric Nephrology

Genetics: How to Integrate into Practice

Rapidly Progressive Glomerulonephritis

Faculty Q&A

Adjourn Live Program

Self-Paced Study

Electrolyte and Acid Base Disorders: Questions & Answers Session - Part 1

Electrolyte and Acid Base Disorders: Questions & Answers Session - Part 2

Dr. Chronic Kidney Disease in the Community: Meeting Them Where They Are

COVID-19 Vaccine in Immunocompromised Patients

Update on Renovascular Disease

Wednesday, August 12, 2026

Welcoming Remarks

Why Do We Reject a Transplant?

Transplant Immunosuppression for the Boards

Faculty Q&A

Immunological Assessment Pre- and Post-Transplant

Early Post-Transplant Management

Faculty Q&A

Donor Evaluation

Late Loss of the Kidney Transplant

Infections in Transplant Recipients

Monitoring Kidney Transplant Patients: Beyond Creatinine

Pre-Transplant Evaluation of Recipients

Faculty Q&A

Late Post-Transplant Medical Complications

Thrombotic Microangiopathies

KEYNOTE: Xenotransplantation

Geriatric Nephrology

Faculty Q&A

Adjourn Live Program

Self-Paced Study

Pre-Transplant Surgical Evaluation of Recipients

Immunologic Basis of Kidney Disease

Use of Checkpoint Inhibitors in Kidney Transplant Recipients

Transplant Cases: Board Review

Transplant Board Review

Poisonings and Intoxications: What a Nephrologist Needs to Know

Thursday, August 13, 2026